Prof Tomas Kalincik
Professorial Fellow, Neurological Outcomes
Department of Medicine
665 Scholarly works
30 Projects
HIGHLIGHTS
2024
Research grants (ARC, NHMRC, MRFF)
New Paradigms in Prevention of Disability in Multiple Sclerosis
2021
Journal article
Associations of Disease-Modifying Therapies with COVID-19 Severity in Multiple Sclerosis
DOI: 10.1212/WNL.00000000000127532018
Research grants (ARC, NHMRC, MRFF)
Arc Training Centre in Cognitive Computing for Medical Technologies (Arc - Central Operating)
2018
Research Grant
Arc Training Centre in Cognitive Computing for Medical Technologies (Arc - Stream 1 & 2)
2015
Journal article
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
DOI: 10.1002/ana.243392014
Journal article
Fingolimod after natalizumab and the risk of short-term relapse
DOI: 10.1212/WNL.00000000000002832013
Journal article
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
DOI: 10.1093/brain/awt281
RECENT SCHOLARLY WORKS
2026
Journal article
Plasma proteome in LGI-1 autoimmune encephalitis
DOI: 10.1186/s12974-026-03851-x2026
Journal article
A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial
DOI: 10.1016/j.jad.2026.1219172026
Journal article
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission
DOI: 10.1016/j.jns.2026.1260662026
Journal article
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
DOI: 10.1177/135245852614606582026
Journal article
Association between pregnancy timing and disability outcomes in women with mild relapse-onset multiple sclerosis.
DOI: 10.1177/135245852614640552026
Journal article
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
DOI: 10.1093/brain/awag2522026
Journal article
Causal effects of multiple sclerosis therapies in left-truncated registry data.
DOI: 10.1177/135245852614599432026
Journal article
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study
DOI: 10.1007/s40263-026-01287-8